maintenance dose glp 1 ‘Maintenance’ doses of GLP-1 medication FITISH GLP-1 MICRODOSING PROGRAM –

For now, stories like Madison are helping people learn what to possibly expect

People should focus on factors that promote long-term skin health and enhance the ability to resist detrimental factors

A.McCoulE

Introduction Glucagon-like peptide-1 receptor agonists (GLP-1RA) are effective therapies for patients with type 2 diabetes (T2D) and/or obesity, particularly for those with coexisting cardiovascular disease and/or high cardiovascular risk [1]

For someone already taking a GLP-1 medication, this reinforces the idea that obesity treatment is not cosmetic its a chronic disease treatment and risk-reduction medication. GLP-1s Users Had Lower Rates of Blood Clots, ER Visits, and Death The study analyzed health records from more than 26,000 adults with obesity and at least one autoimmune disease, such as rheumatoid arthritis, psoriatic arthritis, type 1 diabetes, vitiligo, and celiac disease

Members must be 18+ with a BMI of 35 or higher